A detailed history of Wealthcare Advisory Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 38,541 shares of BMY stock, worth $1.53 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
38,541
Previous 44,143 12.69%
Holding current value
$1.53 Million
Previous $2.26 Million 7.69%
% of portfolio
0.07%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $268,783 - $304,748
-5,602 Reduced 12.69%
38,541 $2.09 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $120,666 - $143,988
-2,489 Reduced 5.34%
44,143 $2.26 Million
Q3 2023

Oct 12, 2023

SELL
$57.89 - $64.73 $81,335 - $90,945
-1,405 Reduced 2.92%
46,632 $2.71 Million
Q2 2023

Jul 17, 2023

SELL
$63.71 - $70.74 $79,446 - $88,212
-1,247 Reduced 2.53%
48,037 $3.07 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $133,128 - $150,997
-2,026 Reduced 3.95%
49,284 $3.42 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $98,405 - $116,526
1,437 Added 2.88%
51,310 $3.69 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $118 - $69,924
910 Added 1.86%
49,873 $3.55 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $500,932 - $551,702
6,898 Added 16.4%
48,963 $3.77 Million
Q1 2022

Apr 15, 2022

SELL
$61.48 - $73.72 $481,634 - $577,522
-7,834 Reduced 15.7%
42,065 $3.07 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $85,003 - $99,094
-1,585 Reduced 3.08%
49,899 $3.11 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $118,754 - $139,105
2,007 Added 4.06%
51,484 $3.05 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $312,707 - $340,538
5,051 Added 11.37%
49,477 $3.31 Million
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $1.08 Million - $1.21 Million
18,171 Added 69.21%
44,426 $2.81 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $78,815 - $89,311
1,365 Added 5.48%
26,255 $1.63 Million
Q3 2020

Oct 29, 2020

BUY
$57.43 - $63.64 $17,688 - $19,601
308 Added 1.25%
24,890 $1.5 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $3,344 - $3,909
61 Added 0.25%
24,582 $1.45 Million
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $58,092 - $84,422
-1,252 Reduced 4.86%
24,521 $1.37 Million
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $50,883 - $66,372
1,034 Added 4.18%
25,773 $1.65 Million
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $31,179 - $36,967
-729 Reduced 2.86%
24,739 $1.26 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $8,700 - $9,621
195 Added 0.77%
25,468 $1.16 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $32,260 - $38,467
-715 Reduced 2.75%
25,273 $1.21 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $43,396 - $56,274
890 Added 3.55%
25,988 $1.35 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $54,803 - $61,814
-993 Reduced 3.81%
25,098 $1.56 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $92,823 - $115,694
-1,837 Reduced 6.58%
26,091 $1.44 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $50,572 - $58,219
-844 Reduced 2.93%
27,928 $1.77 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $839 - $914
14 Added 0.05%
28,772 $1.76 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $1.58 Million - $1.82 Million
28,556 Added 14136.63%
28,758 $1.83 Million
Q2 2017

Aug 29, 2017

BUY
N/A
202
202 $11,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.